Critical Warnings & Restrictions In Canada

Basic Podofilm Information

• INN (International Nonproprietary Name): Podophyllotoxin; Podophyllum Resin or Podophyllin.
• Brand Names Available In Canada (English): Not Specified.
• ATC Code: D06BB04 (Podophyllotoxin / Podophyllum Resin Topical).
• Forms & Dosages: Topical solution 10%, 20%, 25% (resin) in 3–10 mL vials; Topical cream/gel 0.5% in 3–5 g tubes.
• Manufacturers In Canada (English): Not Specified.
• Registration Status In Canada (English): Not Specified.
• OTC / Rx Classification: Prescription (Rx) Only; not OTC except rare low-concentration exceptions.

Immediate Safety First — Who Must Not Use Podofilm/Podophyllum Products

Worry: Is this safe for someone trying a wart remover at home?

Pregnancy is an absolute contraindication because podophyllotoxin and podophyllum products are teratogenic and embryotoxic.

Known hypersensitivity to podophyllotoxin or podophyllum resin means the product must not be used.

Do not apply podophyllotoxin or podophyllum resin to mucous membranes, open wounds or inflamed skin such as inside the vagina, cervix, rectum or urethra.

Patients with extensive skin disease over the treatment site (for example eczema or active psoriasis) should not have topical podophyllotoxin or resin applied.

Podophyllum resin is poisonous in large doses and is more irritant than the pure 0.5% podophyllotoxin formulations.

Patient self-application is limited to 0.5% podophyllotoxin gels or creams; resin solutions at 10–25% must be applied by a healthcare professional.

Advisories For Canadian Practice

Advise pregnancy testing where relevant for people of childbearing potential before starting treatment because of teratogenic risk.

Document informed consent for genital wart treatment, noting the teratogenic warning and application limits.

Confirm prescription-only status and check Health Canada/DIN authorization before dispensing or recommending a product.

If an adverse event is suspected, pharmacists and prescribers should report it to Health Canada’s MedEffect program and document the case in the patient record.

High-Risk Groups

Pregnant people: absolute contraindication; refer to obstetrics or sexual health services for safe alternatives and follow-up.

Elderly patients: skin may be thinner and more prone to irritation and erosion, so monitor the treatment site closely.

Immunocompromised patients, including people living with HIV, have a higher risk of treatment failure and theoretical systemic toxicity with large-area use.

Interaction With Activities

Local skin reactions such as burning, pain or intense irritation can temporarily impair comfort and concentration at work.

Systemic toxicity is rare with 0.5% podophyllotoxin but, if it occurs, symptoms such as dizziness, confusion or severe weakness can make driving or operating machinery unsafe.

Under Canadian workplace safety expectations, avoid heavy machinery or safety-sensitive tasks if systemic symptoms develop after topical application.

Q&A — “Can I Drive After Taking It In Canada?”

Q: Can I drive after using podophyllotoxin topical gel?

A: For typical topical 0.5% podophyllotoxin gel used as directed, systemic absorption is minimal and driving is usually safe.

A: If you experience dizziness, confusion, severe weakness or other systemic symptoms, do not drive and seek urgent medical attention.

Usage Basics For Canadians

INN, Brand Names And Likely Availability In Canada

People searching for podofilm may see different names internationally; the INN for the active pure ingredient is podophyllotoxin.

Crude extracts are labelled as podophyllum resin or podophyllin in some markets.

International brand names in the raw data include Condyline, Warticon and Wartec for the 0.5% formulations and Podowart or Podofilină for resin solutions in some regions.

In Canada, product availability varies and some topical podophyllotoxin products may be available by prescription or via special import; always check Health Canada and DIN listings at the time of dispensing.

Legal Classification Under Health Canada

Classification: These products are generally prescription-only (Rx) because of toxicity and misuse risk.

• Permitted For Self-Application: Podophyllotoxin 0.5% gel/cream where local rules permit.
• Restricted / Professional Use Only: Podophyllum resin solutions (10–25%) — professional application required.
• Special Imports Or Unauthorised Products: Products marketed in other countries may not be authorized in Canada — verify DIN before procurement.

Canadian Dosing Guide

Standard Regimens (Health Canada-Aligned)

Use only Health Canada–approved monograph or a prescriber’s regimen where available.

Podophyllotoxin 0.5% gel/cream: self-apply twice daily to each wart for 3 days, then stop for 4 days; repeat the cycle up to 4 times, not exceeding approximately 6 weeks total.

Resin solutions (10–25% podophyllum resin): must be applied by a healthcare professional, usually once weekly for up to 6 weeks, then washed off after 1–4 hours.

Adjustments For Comorbidities

For people with diabetes or peripheral vascular disease, treat smaller areas and monitor closely for ulceration or secondary infection.

Consider alternatives such as cryotherapy or referral to dermatology if there is poor wound healing risk.

Avoid treating large surface areas to limit systemic absorption; children are generally not recommended to receive podophyllotoxin or resin due to absorption concerns and toxicity risk.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Q: Missed dose instructions and provincial coverage impact?

A: If a podophyllotoxin topical application is missed, skip the missed application and resume the normal schedule; do not double up on doses.

A: Coverage gaps do not change dosing — if a prescription lapses due to provincial plan limits, consult the prescriber or pharmacist for an authorized refill or a special authorization under your provincial plan (for example ODB, PharmaCare, RAMQ).

Interaction Chart (Canadian Context)

Food And Drink Interactions

No specific food interactions are documented with topical podophyllotoxin.

Alcohol and central nervous system depressants may worsen systemic symptoms if an overdose occurs, so moderation is advisable while treating sensitive areas.

Common Drug Conflicts

Systemic interactions are rare because topical 0.5% podophyllotoxin has minimal systemic absorption.

Avoid concurrent application of other strong topical vesicants or irritants over the same area to reduce enhanced local irritation.

In immunosuppressed patients, co-ordinate wart treatment with systemic therapies that suppress bone marrow function and monitor for unusual systemic signs.

• Stop Treatment And Seek Care If…
• Nausea, vomiting, severe abdominal pain, confusion or fainting develop.
• Marked bruising, persistent fever, or signs of bone marrow suppression such as unusual bleeding.
• Severe local ulceration or spreading infection at the treatment site.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Patients commonly report that 0.5% podophyllotoxin is effective for small external warts but that local irritation is frequent.

Search phrases seen in multilingual forums include Podowart and podophyllin wart removal Canada as people look for wart treatment options and DIY approaches.

Common patient comments request clearer written instructions and reassurance about pregnancy safety and coverage.

Community Pharmacy Feedback

Community pharmacists report that resin preparations are rarely stocked and that requests typically lead to a special order or substitution with Health Canada–approved alternatives such as imiquimod or referral for cryotherapy.

Pharmacists emphasise pregnancy screening, documentation of consent for genital wart treatments and providing explicit written instructions for home application.

• Typical Patient Concerns: pain during treatment, cost, pregnancy safety, and whether it will return.
• Pharmacist Counselling Points: pregnancy test if applicable, limit area treated, hands hygiene, and follow-up.
• Trending Search Phrases: Podofilm Canada, podophyllin wart removal Canada, topical wart medication.

Access & Purchase Options

National Pharmacy Chains And In-Store Realities

Major Canadian chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu will dispense prescription podophyllotoxin products if a product has a valid DIN or via pharmacist-supervised special importation.

Most stores will not stock podophyllum resin solutions because these are professional-use products and are more irritant and toxic.

Expect to present a prescription, valid ID and pregnancy status as required when collecting a prescription for wart treatment.

Online Pharmacies In Canada & Provincial Restrictions

Only provincially licensed Canadian online pharmacies should be used for safe ordering and counselling; avoid unverified international online sellers.

Some low-concentration formulations available in other countries may be unauthorized imports in Canada and may lack a DIN or Canadian labelling.

• Purchase Checklist: confirm DIN; ensure pharmacist counselling; confirm pregnancy testing where relevant; verify shipping is allowed to your province.

In our online pharmacy, podofilm is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Mechanism & Pharmacology

Patient-Friendly Explanation

Podophyllotoxin works by stopping cell division in wart tissue.

It interferes with microtubule formation and mitosis, causing wart cells to die and the lesion to slough off over time.

Resin preparations contain podophyllotoxin plus other plant constituents and are generally more irritant and toxic than the pure 0.5% formulations.

Clinical Terms & Regulatory Classification

ATC Code D06BB04 covers topical podophyllotoxin and podophyllum resin formulations used for wart treatment.

Podophyllotoxin formulations at 0.5% have minimal systemic absorption when used as directed.

Key Definitions:

• INN: International Nonproprietary Name — podophyllotoxin or podophyllum resin.
• Resin Vs Podophyllotoxin: resin is crude extract and more irritant; podophyllotoxin is the purified active ingredient used in safer low-concentration gels.
• ATC Code: D06BB04.
• DIN: Drug Identification Number — required to confirm Health Canada authorization.

Indications & Off-Label Uses In Canada

Approved Indications (DIN)

Typical approved uses from source data include external genital and perianal warts (condylomata acuminata) and some external cutaneous warts depending on the product monograph.

Always check the product’s DIN and monograph for the exact licensed indications before prescribing or dispensing.

Common Off-Label Practices (Canadian Physicians)

Off-label uses sometimes include small plantar or periungual warts under specialist direction, but caution is required because of toxicity and absorption risks.

Resin preparations are seldom used off-label because of higher irritant potential and poisoning risk.

• Approved Vs Off-Label: use the product monograph and record rationale for any off-label use.
• Clinician Considerations: document consent and monitor closely.
• Contraindicated Sites: vagina, cervix, urethra and rectum — do not use on mucosal surfaces.

Key Clinical Findings

Canadian And International Studies 2022–2025

Recent literature supports podophyllotoxin 0.5% as effective for small external genital warts, with cure rates comparable to other topical agents and generally fewer systemic adverse events than resin solutions.

Resin solutions remain effective when applied professionally but are linked to more intense local adverse events and carry higher misuse risk.

Ongoing Health Canada Safety Monitoring

Healthcare professionals are encouraged to report suspected adverse reactions to Health Canada’s MedEffect program.

Pharmacists and prescribers should document severe local reactions, systemic signs or any suspected teratogenic exposure and liaise with the prescriber and public health as needed.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Common alternatives in Canada include imiquimod (Aldara) cream, professional trichloroacetic acid treatment, cryotherapy with liquid nitrogen and surgical removal in selected cases.

Pros And Cons Checklist

• Selection Checklist: consider size and location of wart, pregnancy status, immune status and patient preference when choosing therapy.

Common Questions From Canadian Patients

• How Long Until I See Results? Expect a partial response within 2–4 weeks; full clearance may require multiple cycles over several weeks.
• Is Treatment Covered By Provincial Plans? Coverage varies by province and product; many podophyllotoxin products require private insurance or special authorization — see Coverage & Purchase Comparison Table.
• Can I Treat Myself At Home? Only 0.5% podophyllotoxin gel/cream is suitable for self-application; resin solutions must be applied by a clinician. Do not self-treat during pregnancy or on mucosal surfaces.
• What Side Effects Should Prompt Urgent Care? Severe pain, systemic symptoms such as nausea, vomiting or confusion, signs of infection or significant ulceration require emergency assessment.
• Brief Pharmacist Counselling Script: “This is podophyllotoxin 0.5% gel for external warts. Apply only to the wart, twice daily for 3 days, then stop for 4 days. Repeat up to 4 cycles. Avoid pregnancy, limit treated area and wash hands after use. If you have severe burning or any systemic symptoms, stop and seek care.”

Coverage & Purchase Comparison Table

Comparison Table — Province/Plan, Coverage Status, Typical Patient Cost, Prescription Required

Step-By-Step Purchase Checklist For Canadian Patients

1. Obtain a prescription from your prescriber documenting indication and pregnancy status.
2. Verify the product’s DIN and whether provincial coverage or special authorization is required.
3. Pharmacy checks stock or arranges special order or import if appropriate.
4. Pharmacist provides counselling and written instructions, including red-flag signs.
5. Arrange follow-up with the prescriber or clinic if no improvement after the recommended cycles.

Registration & Regulation

Health Canada Approval

Confirm a product’s Health Canada status and DIN prior to dispensing or recommending it.

Products approved in other jurisdictions (for example the UK, EU or Romania) may not be authorized in Canada and importation rules apply.

DIN Number And Labelling Requirements

A Health Canada DIN confirms product evaluation for safety, efficacy and quality.

Label must meet Canadian requirements; check bilingual labelling where mandated and read the package insert for contraindications and storage instructions.

• Regulatory Checks: DIN, expiry date, lot number, bilingual label and MedEffect reporting information.

Storage & Handling

Standard Canadian Household Conditions

Store podophyllotoxin or podophyllum resin products between 15–30°C, protected from light and out of reach of children.

Keep the product in the original container with a child-resistant cap where provided and avoid storing in bathrooms where heat and humidity fluctuate.

Cold-Chain Requirements (Where Applicable)

Most topical podophyllotoxin and resin formulations do not require refrigeration but should not be exposed to extreme heat such as in parked cars.

For imported items, verify transport conditions and expiry dates on arrival.

• Pharmacist Checklist: check storage temperature, expiry, provide patient counselling points and advise safe disposal (hazardous waste protocols if contaminated).

Guidelines For Proper Use

Canadian Pharmacist Guidance

Provide both written and verbal instructions with every dispensed topical wart product.

Key counselling points: treat only the designated lesions; avoid surrounding healthy skin; wash hands before and after application; do not cover treated area unless advised by the prescriber.

Emphasise complete avoidance during pregnancy and recommend effective contraception for people of childbearing potential during treatment.

Provincial Health Authority Recommendations

Follow local sexual health clinic protocols for genital wart management and refer complicated cases — such as large lesions, immunocompromised patients or pregnancy — to specialists.

Document informed consent and any adverse effects; arrange timely follow-up if there is no improvement after the expected treatment cycles.

• Follow-Up Checklist: monitor the site weekly, stop treatment if severe irritation appears, report adverse events to Health Canada and schedule clinic review if no improvement after recommended cycles.

Short Pharmacist Counselling Script:

“Apply a small amount of gel directly to each wart only, twice daily, for three days, then stop for four days; repeat up to four cycles. Avoid pregnancy, keep area clean and contact your clinic if severe pain or systemic symptoms develop.”

Red-Flag Checklist For Urgent Referral:

Widespread blistering, systemic symptoms (nausea, vomiting, confusion), heavy bleeding, or signs of infection at the treatment site.

Delivery Across Canada (English)